Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    April 2024
  1. SUSANTO AC, Hartajanie L, Wu CC
    alpha?Phellandrene enhances the apoptosis of HT?29 cells induced by 5?fluorouracil by modulating the mitochondria?dependent pathway.
    Oncol Rep. 2024;51:61.
    PubMed     Abstract available


    March 2024
  2. LI XL, Zhou J, Xia CJ, Min H, et al
    [Corrigendum] PRIMA?1(met) induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK?ULK1?Vps34 signaling cascade.
    Oncol Rep. 2024;51:44.
    PubMed     Abstract available


    February 2024
  3. ZHANG M, Xiang F, Sun Y, Liu R, et al
    Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression.
    Oncol Rep. 2024;51:27.
    PubMed     Abstract available


  4. CHO SJ, Jeong BY, Yoon SH, Park CG, et al
    Rab25 suppresses colon cancer cell invasion through upregulating claudin?7 expression.
    Oncol Rep. 2024;51:26.
    PubMed     Abstract available


  5. CAO R, Guo S, Min L, Li P, et al
    Roles of Rictor alterations in gastrointestinal tumors (Review).
    Oncol Rep. 2024;51:37.
    PubMed     Abstract available


    January 2024
  6. CHI J, Liu S, Wu Z, Shi Y, et al
    [Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR?181a?5p/ROCK2 axis.
    Oncol Rep. 2024;51:13.
    PubMed     Abstract available


  7. LU M, Hu X, Cheng C, Zhang Y, et al
    RPF2 mediates the CARM1?MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
    Oncol Rep. 2024;51:11.
    PubMed     Abstract available


    December 2023
  8. ZHANG J, Li C, Sun L, Sun D, et al
    P53?microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
    Oncol Rep. 2023;50:219.
    PubMed     Abstract available


    November 2023
  9. DING M, Yan J, Chao G, Zhang S, et al
    Application of artificial intelligence in colorectal cancer screening by colonoscopy: Future prospects (Review).
    Oncol Rep. 2023;50:199.
    PubMed     Abstract available


    October 2023
  10. SIM MK, Park JE, Kim SR, Lee J, et al
    Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation.
    Oncol Rep. 2023;50:178.
    PubMed     Abstract available


  11. ALZAHRANI SM, Al Doghaither HA, Al-Ghafari AB, Pushparaj PN, et al
    5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review).
    Oncol Rep. 2023;50:175.
    PubMed     Abstract available


  12. YAMAMOTO T, Shiburo R, Moriyama Y, Mitamura K, et al
    Protein components of maple syrup as a potential resource for the development of novel anti‑colorectal cancer drugs.
    Oncol Rep. 2023;50:179.
    PubMed     Abstract available


  13. CHEN WS, Zhang X, Zhao ZF, Che XM, et al
    MBNL1?AS1 attenuates tumor cell proliferation by regulating the miR?29c?3p/BVES signal in colorectal cancer.
    Oncol Rep. 2023;50:191.
    PubMed     Abstract available


    September 2023
  14. LIU Z, Fan L, Niu D, Chen M, et al
    Copper (II) complex of salicylate phenanthroline induces the apoptosis of colorectal cancer cells, including oxaliplatin‑resistant cells.
    Oncol Rep. 2023;50:170.
    PubMed     Abstract available


    July 2023
  15. FENG WQ, Zhang YC, Gao H, Li WC, et al
    FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through beta‑catenin nuclear localization.
    Oncol Rep. 2023;50:134.
    PubMed     Abstract available


  16. TANG B, Liang W, Liao Y, Li Z, et al
    [Retracted] PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2023;50:137.
    PubMed     Abstract available


    June 2023
  17. MA F, Lin Y, Ni Z, Chen T, et al
    Therapeutic effects of natural polyphenols on colorectal adenomas: Focus on preclinical studies (Review).
    Oncol Rep. 2023;49:112.
    PubMed     Abstract available


  18. ZHOU J, Chen S, Liu J, Du J, et al
    Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells.
    Oncol Rep. 2023;49:129.
    PubMed     Abstract available


  19. GONG JE, Kim JE, Park SH, Lee SJ, et al
    Anti‑tumor effects of an aqueous extract of Ecklonia cava in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells.
    Oncol Rep. 2023;49:128.
    PubMed     Abstract available


    May 2023
  20. WANG C, Xin H, Yan G, Liu Z, et al
    NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA.
    Oncol Rep. 2023;49:89.
    PubMed     Abstract available


  21. SUN LB, Zhao SF, Zhu JJ, Han Y, et al
    [Retracted] Long noncoding RNA UCID sponges miR‑152‑3p to promote colorectal cancer cell migration and invasion via the Wnt/beta‑catenin signaling pathway.
    Oncol Rep. 2023;49:92.
    PubMed     Abstract available


  22. QIAN K, Zhang J, Lu J, Liu W, et al
    [Retracted] FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.
    Oncol Rep. 2023;49:107.
    PubMed     Abstract available


    April 2023
  23. KANG M, Su Z
    Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
    Oncol Rep. 2023;49:66.
    PubMed     Abstract available


  24. KIM HJ, Hong I, Roh S, Kim S, et al
    High expression of LY6E is an independent prognostic factor of colorectal cancer patients.
    Oncol Rep. 2023;49:80.
    PubMed     Abstract available


    March 2023
  25. HARATA S, Suzuki T, Takahashi H, Hirokawa T, et al
    AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells.
    Oncol Rep. 2023;49:52.
    PubMed     Abstract available


  26. XIE Y, Zhang Y, Liu X, Cao L, et al
    miR‑151a‑5p promotes the proliferation and metastasis of colorectal carcinoma cells by targeting AGMAT.
    Oncol Rep. 2023;49:50.
    PubMed     Abstract available


  27. KIM JE, Lee SK, Park J, Jung MJ, et al
    Buddlejasaponin IV induces apoptotic cell death by activating the mitochondrial‑dependent apoptotic pathway and reducing alpha(2)beta(1) integrin‑mediated adhesion in HT‑29 human colorectal cancer cells.
    Oncol Rep. 2023;49:58.
    PubMed     Abstract available


    February 2023
  28. LINDEMANN A, Brandes F, Borrmann M, Meidert AS, et al
    Anesthetic‑specific lncRNA and mRNA profile changes in blood during colorectal cancer resection: A prospective, matched‑case pilot study.
    Oncol Rep. 2023;49:28.
    PubMed     Abstract available


  29. LOMBARDI P, Aimar G, Peraldo-Neia C, Bonzano A, et al
    Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
    Oncol Rep. 2023;49:31.
    PubMed     Abstract available


  30. JIANG T, Li H, Jiang R, Li H, et al
    [Retracted] Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑kappaB signaling pathway.
    Oncol Rep. 2023;49:40.
    PubMed     Abstract available


    January 2023
  31. TANG Y, Yi X, Zhang X, Liu B, et al
    Microcystin‑leucine arginine promotes colorectal cancer cell proliferation by activating the PI3K/Akt/Wnt/beta‑catenin pathway.
    Oncol Rep. 2023;49:18.
    PubMed     Abstract available


  32. ROSTKOWSKA O, Olejniczak-Keder A, Spychalski P, Szarynska M, et al
    Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro.
    Oncol Rep. 2023;49:21.
    PubMed     Abstract available


    November 2022
  33. URH K, Zidar N, Tomazic A, Bostjancic E, et al
    Intratumor heterogeneity of cancer stem cellrelated genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  34. LIU F, Su D, Zhang H, Lin HC, et al
    Clinical implications of the oralgut microbiome axis and its association with colorectal cancer (Review).
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  35. CIZAUSKAITE A, Simcikas D, Schultze D, Kallifatidis G, et al
    Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    October 2022
  36. LIU X, Wang Y, Zhao J
    [Retracted] MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  37. SI Y, Li L, Zhang W, Liu Q, et al
    GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/betacatenin and Notch signalling pathways.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    June 2022
  38. DAITOKU N, Miyamoto Y, Hiyoshi Y, Tokunaga R, et al
    Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  39. NAKAI N, Hara M, Takahashi H, Shiga K, et al
    Cancer cellinduced tissue inhibitor of metalloproteinase1 secretion by cancerassociated fibroblasts promotes cancer cell migration.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    May 2022
  40. SATO N, Sakai N, Furukawa K, Takayashiki T, et al
    Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  41. ZHAO P, Zhou P, Tang T, Si R, et al
    Levels of circulating mast cell progenitors and tumourinfiltrating mast cells in patients with colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  42. LEE MH, Hong SH, Park C, Kim GY, et al
    [Corrigendum] Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  43. XU Y, Liu X, Zhang H, Zhu Z, et al
    [Corrigendum] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  44. YOSHIMOTO T, Shimada M, Tokunaga T, Nakao T, et al
    Blue light irradiation inhibits the growth of colon cancer and activation of cancerassociated fibroblasts.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    April 2022
  45. LI J, Xu J, Yan X, Jin K, et al
    [Retracted] MicroRNA485 plays tumoursuppressive roles in colorectal cancer by directly targeting GAB2.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  46. HAN J, Liu Z, Wang N, Pan W, et al
    [Retracted] MicroRNA874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting Xlinked inhibitor of apoptosis protein.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  47. ZHAO J, Xu J, Zhang R
    [Retracted] MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  48. SUZUKI T, Hirokawa T, Maeda A, Harata S, et al
    ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5fluorouracil by inhibiting repair of DNA damage.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    March 2022
  49. YAN Z, Zhou Y, Yang Y, Zeng C, et al
    Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    February 2022
  50. ZHANG S, Yu M, Chen D, Li P, et al
    Role of MRIbased radiomics in locally advanced rectal cancer (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    January 2022
  51. ZEYA B, Nafees S, Imtiyaz K, Uroog L, et al
    Diosmin in combination with naringenin enhances apoptosis in colon cancer cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  52. CHEN W, Dai G, Qian Y, Wen L, et al
    PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  53. TAK E, Kim M, Cho Y, Choi S, et al
    Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    December 2021
  54. XIE Y, Wang F, Yu J, Zhang J, et al
    Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    November 2021
  55. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    August 2021
  56. ASANO T, Ohishi T, Takei J, Nakamura T, et al
    AntiHER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    June 2021
  57. ZHANG YL, Wen XD, Guo X, Huang SQ, et al
    Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45alpha/JNK/cJun signalling pathway.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    May 2021
  58. FREUND E, Miebach L, Stope MB, Bekeschus S, et al
    Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    March 2021
  59. SZCZYGIEL A, Anger-Gora N, Wegierek-Ciura K, Mierzejewska J, et al
    Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cellbased vaccines in murine colon carcinoma.
    Oncol Rep. 2021;45:945-962.
    PubMed     Abstract available


  60. VERDINA A, Di Segni M, Amoreo CA, Sperduti I, et al
    HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
    Oncol Rep. 2021;45:899-910.
    PubMed     Abstract available


  61. WANG X, Song Z, Hu B, Chen Z, et al
    MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I alpha1.
    Oncol Rep. 2021;45:933-944.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.